rxstat › Shortages › Carvedilol

Carvedilol shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Carvedilol products are in shortage in Canada (8 of 30 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 24, 2026.
Products affected
8 of 30
In shortage since
Jan 9, 2024
Est. full return
Jul 24, 2026
Reports on file
73
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP-CARVEDILOL
3.125MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368897 · since May 12, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
3.125MG · TABLET · TEVA CANADA LIMITED
DIN 02252309 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
6.25MG · TABLET · TEVA CANADA LIMITED
DIN 02252317 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CARVEDILOL
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02252325 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
12.5MG · TABLET · APOTEX INC
DIN 02247935 · since Jun 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
3.125MG · TABLET · APOTEX INC
DIN 02247933 · since Dec 13, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
6.25MG · TABLET · APOTEX INC
DIN 02247934 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CARVEDILOL
25MG · TABLET · APOTEX INC
DIN 02247936 · since Jan 9, 2024, no end estimate · Disruption of the manufacture of the drug.
Anticipated
CARVEDILOL
6.25MG · TABLET · SANIS HEALTH INC
DIN 02364921 · Disruption of the manufacture of the drug.
Resolved
JAMP-CARVEDILOL
6.25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368900 · ended Mar 27, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CARVEDILOL
25MG · TABLET · TEVA CANADA LIMITED
DIN 02252333 · ended Oct 1, 2025 · Disruption of the manufacture of the drug.
Resolved
CARVEDILOL
3.125MG · TABLET · SANIS HEALTH INC
DIN 02364913 · ended Nov 25, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Carvedilol is currently affected by 8 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Carvedilol is classified under “BETA BLOCKING AGENTS” (ATC C07AG).

Recent changes

Common questions

When will Carvedilol be back in stock in Canada?

The latest manufacturer estimate is Jul 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Carvedilol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (beta blocking agents)

Widespread shortageLabetalol4 of 8 reported products affected · est. return May 8, 2026Widespread shortageNadolol2 of 2 reported products affected · est. return Jun 26, 2026Partial shortageAcebutolol2 of 21 reported products affectedPartial shortageAtenolol7 of 34 reported products affectedPartial shortageMetoprolol4 of 37 reported products affected · est. return Dec 31, 2026Partial shortagePindolol2 of 10 reported products affected

All beta blocking agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.